Targeting Microbiota 2025 Agenda
Day 1 - November 5, 2025
Keynote Speech: Microbiota 2025: Vision and Challenges
Session 1: Microbiota in Health & Disease: Recent Advances and Mechanistic Insights
- Microbiome-host interactions
- Impact of microbiota quality on immune function, metabolism, neurological health and other diseases
- Metabolites and biomarkers for disease prediction and management
- Mechanistic insights into dysbiosis and its impact on chronic diseases
- New methodologies for studying microbiome composition and function
Session 2: Microbiota Medicine: Major Advances and Clinical Translation
- Translating microbiome research into clinical practice
- Butyrate & short-chain fatty acids: Results of clinical applications
- Phage Therapy: Emerging applications and challenges
- Advances in probiotics, prebiotics, postbiotics, and microbiome-based therapies
- Fecal microbiota transplantation (FMT): updates on efficacy and safety
- Next-generation microbiome therapeutics and drug development
- Clinical trial updates and case studies on microbiota-targeted interventions
Day 2 - November 6, 2025
Session 3: Innovations in Microbiota Research and Therapeutics
- Novel innovative technologies in microbiome research (AI, multi-omics, and big data)
- Extracellular Vesicles and Exosomes: Where is the Target?
- Synthetic biology applications for microbiota modulation
- Novel drug delivery systems targeting the microbiome
- Personalized microbiota interventions for precision medicine
- The future of microbiome-based diagnostics and therapeutics
Concluding Remarks: Microbiota Medicine: Can we Talk about a Revolution?
Targeting Microbiota 2025 Awards
End of Targeting Microbiota 2025
International Society of Microbiota
Press Releases | LinkedIn | Facebook
